Regulators and independent advisors are meeting Thursday to discuss promising data from Pfizer’s clinical trials, and experts say they expect emergency use authorization to be granted.
↧
Regulators and independent advisors are meeting Thursday to discuss promising data from Pfizer’s clinical trials, and experts say they expect emergency use authorization to be granted.